This is relevant for prospective studies on PPARγ ligands and AnxA1, as knowing that inhibition of MMP-9 secretion is dependent on PPARγ makes it more likely that other PPARγ ligands studied for treatment of IBD would have the same effect in preventing AnxA1 cleaving. The gene discussed is ANXA1; the disease is inflammatory bowel disease.